Turkish Tourists Flock to Greece as Rising Costs Deter Greek Travelers to Turkey 5 Market Factors to Watch as Trading Opens Insights from Investopedia Jim Cramer Expresses Disappointment Over Toll Brothers Outlook DOJs 68 Billion Enforcement Push Highlights Nonprofit Fraud Cases Not a Surge in Fraud Itself PL Asset Management CIO Sees Opportunity in Indian Equities Amid Sentiment Weakness USChina Trade Dialogue Resurfaces as APEC Ministers Gather APPS Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction APYX Q1 2026 Earnings EPS Beats Expectations Despite Revenue Uncertainty DARE Q1 2026 Earnings Narrowerthanexpected loss surprises as no revenue reported FTC Solar Q1 2026 Earnings WiderThanExpected Loss Overshadowed by Positive Stock Reaction ULCC Q1 2026 Earnings Narrowerthanexpected loss as cost discipline aids results ASML Q1 2026 Earnings EPS Beats Estimates by 71 Shares Edge Higher SL Green Realty SLG Rises 252 as Office REIT Tests Key Resistance Zone BWX Technologies BWXT Tests Key Support After 164 Decline Defense Sector Headwinds May Persist BlackRock ESG Capital Allocation Term Trust ECAT Holds Steady Near Resistance at 1553 Antalpha Platform Holding Company ANTA Faces Selling Pressure as Shares Dip 220 Air Industries Group AIRI Rallies to 307 Testing Key Resistance Levels Klarna Partners With EZContacts to Expand Flexible Payment Options in the Vision Care Sector JUNS Q4 2025 Earnings Narrower Loss Surprises Yet Stock Falls on PreRevenue Path Precigen Inc PGEN Holds Steady at 424 as Stock Nears Key Support Level FBLG Q1 2026 Earnings Modest EPS Miss Highlights PreRevenue Biotech Path ARMOUR Residential REIT Inc ARR Q1 2026 Earnings BottomLine Beat Driven by Strong Net Interest Margin Performance SpaceX IPO Speculation Nvidia Earnings Impact and Bezos AI Caution Key Market Drivers Concentrix Corporation CNXC Q1 2026 Earnings EPS Miss Despite Slight Revenue Growth Stock Rises SpaceX Scrubs Starship Test Flight Targets Friday for 12th Launch Amid V3 Debut BW Q1 2026 Earnings WiderthanExpected Loss as Stock Jumps 7 A Mixed Signal for Investors Castle Biosciences Q1 2026 Earnings EPS Beat Slightly Narrower Loss Stock Rises 26